Mesa Nilda: insider trades.
Mesa Nilda reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($115K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Mesa Nilda
Companies
| Company | Relationship | Transactions |
|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | UNITED THERAPEUTICS Corp | M | 130 | $110.86 | 6,560 | Form 4 |
| 2026-09-14 | UNITED THERAPEUTICS Corp | S | 130 | $505.79 | 6,430 | Form 4 |
| 2026-09-14 | UNITED THERAPEUTICS Corp | S | 98 | $505.98 | 5,580 | Form 4 |
| 2026-07-09 | UNITED THERAPEUTICS Corp | M | 650 | $0 | 5,678 | Form 4 |
Questions
What stock did Mesa Nilda buy or sell?
Mesa Nilda reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($115K), across 1 company.
Is Mesa Nilda the same person as other filers with this name?
This page covers SEC CIK 1756697 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mesa-nilda-1756697.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.